P2X1 receptors localized in lipid rafts mediate ATP motor responses in the human vas deferens longitudinal muscles

Biology of Reproduction

Volumn 90, Issue 2, 2014, Pages

  Donoso, María Verónica ^a,b   Norambuena, Andrés ^a   Navarrete, Camilo ^a   Poblete, Inés ^a   Velasco, Alfredo ^c   Huidobro Toro, Juan Pablo ^a,b  

^a PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

^b UNIVERSIDAD DE SANTIAGO DE CHILE   (Chile)

^c CLÍNICA SANTA MARÍA   (Chile)

Author keywords

ATP induced contractility; Human vas deferens; P2X receptor desensitization; P2X1 receptors; P2X1 receptors in lipid rafts; Sympathetic cotransmission

Indexed keywords

ADENOSINE TRIPHOSPHATE; ALPHA,BETA METHYLENEADENOSINE TRIPHOSPHATE; FLOTILLIN 1; LIPID; OLIGOMER; PURINERGIC P2X1 RECEPTOR; SUCROSE; TISSUE EXTRACT;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL MEMBRANE; CONTROLLED STUDY; DESENSITIZATION; ELECTRIC FIELD; ELECTROSTIMULATION; EVOKED MUSCLE RESPONSE; EX VIVO STUDY; HUMAN; HUMAN CELL; HUMAN TISSUE; LIPID RAFT; MOTOR ACTIVITY; NONHUMAN; PLASMA CELL; PRIORITY JOURNAL; PROSTATE; PROTEIN ANALYSIS; PROTEIN FUNCTION; PROTEIN LOCALIZATION; RAT; SMOOTH MUSCLE; SUCROSE GRADIENT; ULTRACENTRIFUGATION; VAS DEFERENS; WESTERN BLOTTING; ADULT; AGED; ANIMAL; DRUG EFFECTS; IN VITRO STUDY; MALE; METABOLISM; MIDDLE AGED; MUSCLE CONTRACTION; PHYSIOLOGY; PROTEIN TRANSPORT; SPRAGUE DAWLEY RAT;

ADENOSINE TRIPHOSPHATE; ADULT; AGED; ANIMALS; ELECTRIC STIMULATION; HUMANS; IN VITRO TECHNIQUES; MALE; MEMBRANE MICRODOMAINS; MIDDLE AGED; MUSCLE CONTRACTION; MUSCLE, SMOOTH; PROTEIN TRANSPORT; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, PURINERGIC P2X1; VAS DEFERENS;

EID: 84899911577     PISSN: 00063363     EISSN: 15297268     Source Type: Journal    
DOI: 10.1095/biolreprod.113.109660     Document Type: Article

References (28)

1. Smyth LM, Breen LT, Mutafova-Yambolieva VN. Nicotinamide adenine dinucleotide is released from sympathetic nerve terminals via a botulinum neurotoxin A-mediated mechanism in canine mesenteric artery. Am J Physiol Heart Circ Physiol 2006; 290:H1818-H1825.
2. Donoso MV, Hermosilla D, Navarrete C, Alvarez P, Lillo JG, Huidobro-Toro JP. Reciprocal sympatho-sensory control: functional role of nucleotides and calcitonin gene-related peptide in a peripherals neuroeffector junction. Neuroscience 2012; 203:216-229.
3. Westfall DP, Todorov LD, Mihaylova-Todorova ST, Bjur RA. Differences between the regulation of noradrenaline and ATP release. J Auton Pharmacol 1996; 16:393-395.
4. Huidobro-Toro JP, Parada S. Co-transmission in the rat vas deferens: postjunctional synergism of noradrenaline and adenosine 50-triphosphate. Neurosci Lett 1988; 85:339-344.
5. von Kügelgen I, Starke K. Release of noradrenaline and ATP by electrical stimulation and nicotine in guinea-pig vas deferens. Naunyn Schmiedebergs Arch Pharmacol 1991; 344:419-429.
6. Honner V, Docherty JR. Investigation of the subtypes of alpha1-adrenoceptor mediating contractions of rat vas deferens. Br J Pharmacol 1999; 128:1323-1331.
7. Holmquist F, Hedlund H, Andersson KE. Effects of the alpha 1-adrenoceptor antagonist R-(-)-YM12617 on isolated human penile erectile tissue and vas deferens. Eur J Pharmacol 1990; 186:87-93.
8. Medina P, Segarra G, Chuan P, Domenech C, Vila JM, Aldasoro M, Lluch S. Vasopressin receptors involved in adrenergic neurotransmission in the circular muscle of the human vas deferens. Eur J Pharmacol 1998; 355: 41-49.
9. Medina P, Segarra G, Mauricio MD, Vila JM, Chuan P, Lluch S. Modulation of adrenergic responses of human vas deferens by K{Thorn} channel inhibitors. Urology 2010; 76:1518.e7-1518.e12.
10. Sanger GJ, Ellis ES, Harries MH, Tilford NS, Wardle KA, Benham CD. Rank-order inhibition by omega-conotoxins in human and animal autonomic nerve preparations. Eur J Pharmacol 2000; 388:89-95.
11. Banks FC, Knight GE, Calvert RC, Thompson CS, Morgan RJ, Burnstock G. The purinergic component of human vas deferens contraction. Fertil Steril 2006; 85:932-939.
12. Amobi NI, Guillebaud J, Smith IC. Perspective on the role of P2Xpurinoceptor activation in human vas deferens contractility. Exp Physiol 2012; 97:583-602.
13. Allsopp RC, Evans RJ. The intracellular amino terminus plays a dominant role in desensitization of ATP-gated P2X receptor ion channels. J Biol Chem 2011; 286:44691-44701.
14. Coddou C, Yan Z, Obsil T, Huidobro-Toro JP, Stojilkovic SS. Activation and regulation of purinergic P2X receptor channels. Pharmacol Rev 2011; 63:641-683.
15. Burnstock G, Kennedy C. Is there a basis for distinguishing two types of P2-purinoceptor? Gen Pharmacol 1985; 16:433-440.
16. Valera S, Hussy N, Evans RJ, Adami N, North RA, Surprenant A, Buell G. A new class of ligand-gated ion channel defined by P2X receptors for extracellular ATP. Nature 1994; 371:516-519.
17. Dohle GR, Diemer T, Kopa Z, Krausz C, Giwercman A, Jungwirth A; European Association of Urology Working Group on Male Infertility. European Association of Urology guidelines on vasectomy. Eur Urol 2012; 61:159-163.
18. Sharlip ID, Belker AM, Honig S, Labrecque M, Marmar JL, Ross LS, Sandlow JI, Sokal DC; American Urological Association. Vasectomy: AUA guideline. J Urol 2012; 188:2482-2491.
19. Rettinger J, Braun K, Hochmann H, Kassack MU, Ullmann H, Nickel P, Schmalzing G, Lambrecht G. Profiling at recombinant homomeric and heteromeric rat P2X receptors identifies the suramin analogue NF449 as a highly potent P2X1 receptor antagonist. Neuropharmacology 2005; 48: 461-468.
20. Norambuena A, Poblete MI, Donoso MV, Espinoza CS, González A, Huidobro-Toro JP. P2Y1 receptor activation elicits its partition out of membrane rafts and its rapid internalization from human blood vessels: implications for receptor signaling. Mol Pharmacol 2008; 74: 1666-1677.
21. Hattori M, Gouaux E. Molecular mechanism of ATP binding and ion channel activation in P2X receptors. Nature 2012; 485:207-212. 22. Lalo U, Roberts JA, Evans RJ. Identification of human P2X1 receptorinteracting proteins reveals a role of the cytoskeleton in receptor regulation. J Biol Chem 2011; 286:30591-30599.
22. Lalo U, Roberts JA, Evans RJ. Identification of human P2X1 receptorinteracting proteins reveals a role of the cytoskeleton in receptor regulation. J Biol Chem 2011; 286:30591-30599.
23. Mulryan K, Gitterman DP, Lewis CJ, Vial C, Leckie BJ, Cobb AL, Brown JE, Conley EC, Buell G, Pritchard CA, Evans RJ. Reduced vas deferens contraction and male infertility in mice lacking P2X1 receptors. Nature 2000; 403:86-89.
24. Lalo U, Allsopp RC, Mahaut-Smith MP, Evans RJ. P2X1 receptor mobility and trafficking; regulation by receptor insertion and activation. J Neurochem 2010; 113:1177-1187.
25. Lalo U, Jones S, Roberts JA, Mahaut-Smith MP, Evans RJ. Heat shock protein 90 inhibitors reduce trafficking of ATP-gated P2X1 receptors and human platelet responsiveness. J Biol Chem 2012; 287:32747-32754.
26. Allen JA, Halverson-Tamboli RA, Rassenick MM. Lipid raft microdomains and neurotransmitter signalling. Nat Rev Neurosci 2007; 8: 128-140.
27. Medina P, Segarra G, Torondel B, Chuan P, Domenech C, Vila JM, Lluch S. Inhibition of neuroeffector transmission in human vas deferens by sildenafil. Br J Pharmacol 2000; 131:871-874.
28. Medina P, Segarra G, Mauricio MD, Vila JM, Chuan P, Lluch S. Role of calcium-activated K{Thorn} channels and Na{Thorn} K{Thorn} ATPase in prostaglandin1-and E2-induced inhibition of the adrenergic response in human vas deferens. Biochem Pharmacol 2011; 82:65-71.